IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

Maloney, D G

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 1997 - 3266-74 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.1997.15.10.3266 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Disease Progression
Drug Administration Schedule
Female
Humans
Immunoglobulins--analysis
Immunotherapy
Infusions, Intravenous
Lymphocyte Subsets
Lymphoma, B-Cell--immunology
Male
Middle Aged
Recurrence
Rituximab